NeuroEndocrine Tumor Research Foundation (NETRF) Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2019
NCT03879694
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

NeuroEndocrine Tumor Research Foundation (NETRF)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoid Tumor (Phase 1)

Neoplasms (Phase 1)

Neuroendocrine Tumors (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 4